Derivative of turmeric eye drops could treat glaucoma

July 24, 2018, University College London
Turmeric. Source: Pixabay

A derivative of turmeric could be used in eye drops to treat the early stages of glaucoma, finds a new study led by UCL and Imperial College London researchers.

In the new Scientific Reports paper, the researchers report a new method to deliver curcumin, extracted from the yellow spice turmeric, directly to the back of the eye using , overcoming the challenge of curcumin's poor solubility.

The research team found the eye drops can reduce the loss of retinal cells in rats, which is known to be an early sign of glaucoma.

They are also investigating how the eye drops could be used as a diagnostic tool for a range of conditions.

"Curcumin is an exciting compound that has shown promise at detecting and treating the neurodegeneration implicated in numerous eye and brain conditions from glaucoma to Alzheimer's disease, so being able to administer it easily in eye drops may end up helping millions of people," said the study's lead author, Professor Francesca Cordeiro (UCL Institute of Ophthalmology, Western Eye Hospital and Imperial College London).

Glaucoma is a group of eye conditions affecting over 60 million people worldwide that leads to irreversible blindness in 1 in 10 cases. The condition mainly involves the loss of , a type of neuron located near the surface of the retina. Stopping the loss of these cells early on has not yet been achieved, so it is a key focus of glaucoma research.

Curcumin has previously been shown to protect retinal ganglion cells when administered orally. For the current study, the researchers were seeking to find a more reliable method to deliver curcumin. Oral administration is difficult because curcumin has poor solubility, so it does not easily dissolve and get absorbed into the bloodstream, and would require people to take large amounts of tablets (up to 24 a day) that may cause gastrointestinal side effects.

The team developed a novel nanocarrier, wherein the curcumin is contained within a surfactant combined with a stabiliser, both of which are known to be safe for human use and are already in existing eye products. The nanocarrier can be used in eye drops to deliver much higher loads of curcumin than other products in development, increasing the drug's solubility by a factor of almost 400,000, and localises the curcumin in the eyes instead of throughout the body.

The researchers initially tested the product on cells that are used to model glaucoma, before conducting trials in rats with eye conditions involving the loss of retinal ganglion .

After twice-daily use of eye drops in the rats for three weeks, retinal ganglion cell loss was significantly reduced compared to matched controls, and the treatment was found to be well-tolerated with no signs of eye irritation or inflammation.

Having found an effective way to deliver curcumin, the researchers are hopeful that it could also be used to diagnose Alzheimer's disease, as is known to bind to the amyloid beta protein deposits implicated in Alzheimer's, and can be detected in the retina with fluorescence to highlight the malignant proteins.

"We are now researching diagnostic uses for these eye drops alongside other ways to visualise the retina, as eye tests can be an opportunity to detect signs of neurodegeneration with a simple, non-invasive test," said co-lead author Dr. Ben Davis (UCL Institute of Ophthalmology and Imperial College London).

Professor Cordeiro added: "As we live longer, diseases such as and Alzheimer's are steadily increasing. We believe our findings could make a major contribution at helping the lives of people affected by these devastating diseases."

Explore further: Researchers explore anti-inflammatory activity of curcumin

More information: Benjamin M. Davis et al. Topical Curcumin Nanocarriers are Neuroprotective in Eye Disease, Scientific Reports (2018). DOI: 10.1038/s41598-018-29393-8

Related Stories

Researchers explore anti-inflammatory activity of curcumin

January 17, 2018
Extracts of the plant turmeric—the spice that gives Indian curries a yellow color—have been used as an anti-inflammatory treatment in traditional Asian medicine for centuries. Clinical trials of curcumin (the active chemical ...

New evidence suggests a role for curcumin and related compounds in the treatment of cancer and Alzheimer's disease

January 30, 2018
It has long been believed that curcumin, a component of the golden spice (turmeric), has medicinal properties, but problems with its bioavailability and a lack of understanding of how it works have complicated its use.

Contrary to decades of hype, curcumin alone is unlikely to boost health

January 11, 2017
Curcumin, a compound in turmeric, continues to be hailed as a natural treatment for a wide range of health conditions, including cancer and Alzheimer's disease. But a new review of the scientific literature on curcumin has ...

Keto diet protects optic nerve in glaucoma mouse model

May 14, 2018
Switching mice destined to develop glaucoma to a low carbohydrate, high fat diet protects the cells of the retina and their connections to the brain from degeneration, according to research published in JNeurosci. The study ...

Glaucoma drug may have potential to treat Alzheimer's disease

December 9, 2016
A drug which is used to treat the common eye disease glaucoma may have potential as a treatment for Alzheimer's disease, according to scientists at UCL.

Research advance may lead to new treatments for glaucoma

March 22, 2016
Researchers have developed a tool to not only model the underlying disease mechanisms of glaucoma, but also to help discover and test new pharmacological strategies to combat the neurodegeneration that occurs in patients ...

Recommended for you

Outbreak of preventable eye infection in contact lens wearers

September 21, 2018
A new outbreak of a rare but preventable eye infection that can cause blindness, has been identified in contact lens wearers in a new study led by UCL and Moorfields Eye Hospital researchers.

Newly formed blood vessels may contribute to eye disease

September 14, 2018
Newly formed blood vessels may be cracks in the barrier between the bloodstream and the eye, according to a Northwestern Medicine study published in the Proceedings of the National Academy of Sciences.

Eye disease can cause blindness, and it's on the rise

August 29, 2018
A new study into recent cases of ocular syphilis warns increasing numbers of people are at risk of permanent damage to their vision.

INSiGHT identifies unique retinal regulatory genes

August 28, 2018
Vision begins in the retina, a light-sensing neural network in the eye that is critical for our ability observe the world around us. Researches at Baylor College of Medicine, Texas Children's Hospital and the Hospital for ...

Alzheimer's one day may be predicted during eye exam

August 23, 2018
It may be possible in the future to screen patients for Alzheimer's disease using an eye exam.

Researchers find potential new gene therapy for blinding disease

August 20, 2018
The last year has seen milestones in the gene therapy field, with FDA approvals to treat cancer and an inherited blinding disorder. New findings from a team led by University of Pennsylvania vision scientists, who have in ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

shortwave02001
not rated yet Sep 17, 2018
in my country a marijuana based eye drops was developed to reduce the intra ocular pressure in glaucoma a beta blocker was later added to the formula. The developers of the eye drops have just put on the market a sublingual application which uses a lot less active ingredients.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.